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Abstract
Conn’s syndrome is one of the major causes of secondary hypertension. 
Premature hypertension, metabolic alkalosis, and hypokalemia usually 
lead clinicians to suspect the diagnosis. We describe a case of Conn’s 
syndrome in a 28-year-old woman with an unusual presentation of rhab-
domyolysis secondary to hypokalemia and complete bilateral lower limb 
paralysis. An elevated transtubular potassium concentration gradient, 
asymptomatic severe hypertension, and metabolic alkalosis pointed to 
possible primary hyperaldosteronism, which was confirmed by a decrease 
in plasma renin activity (PRA), elevation in plasma aldosterone level and 
elevation of the plasma aldosterone to PRA ratio. Computed tomography 
showed an adrenal tumor in the adrenal gland. Her blood pressure, hypoka-
lemia, and plasma aldosterone level returned to normal after left adrenal-
ectomy, further confirming the diagnosis. Histologic examination showed 
an adrenal gland adenoma. [Tzu Chi Med J 2008;20(4):327–331]
Article info
Article history:
Received: October 19, 2007
Revised: December 19, 2007
Accepted: March 21, 2008
Keywords:
Conn’s syndrome
Hypokalemia
Rhabdomyolysis
*Corresponding author. Division of Nephrology, Buddhist Tzu Chi General Hospital, 
707, Section 3, Chung-Yang Road, Hualien, Taiwan.
E-mail address: fangtechao@yahoo.com.tw
1. Introduction
The presentations of hypokalemia vary from mild 
muscle weakness to cardiac arrhythmias and rhab-
domyolysis [1–5]. The combination of hypertension, 
hypokalemia, and metabolic alkalosis is important for 
a diagnosis of primary aldosteronism [6]. Primary al-
dosteronism is the most common curable condition 
causing secondary hypertension. Idiopathic bilateral 
adrenal hyperplasia and aldosterone-producing ade-
noma are the leading causes of this disease. We de-
scribe a case of typical Conn’s syndrome presenting 
with rhabdomyolysis, hypokalemia, hypertension, and 
metabolic alkalosis. These manifestations led to the 
suspicion of primary aldosteronism, and hormone 
studies showed a decrease in plasma renin activity 
(PRA), an elevation in plasma aldosterone level, and 
an elevation in the ratio of plasma aldosterone to 
PRA. Moreover, adrenal gland computed tomography 
(CT) revealed an adrenal gland tumor. Her blood 
pressure and hypokalemia and plasma aldosterone 
level returned to normal after left adrenalectomy, 
and histologic examination showed adrenal cortical 
adenoma.
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2. Case report
A 28-year-old-woman was admitted with severe weak-
ness and soreness in bilateral lower limbs. Four days 
before admission, she had malaise and weakness, 
which gradually progressed to limb paralysis (lower 
limbs more severe than upper). On the day of admis-
sion, she could not get out of bed or a chair by herself. 
She denied a recent history of trauma to her back 
or lifting heavy objects. She denied fever, cough, or 
changes in urinary habits or bowel movements. She 
did not have a history of abnormal blood pressure. She 
did not use laxatives, diuretics or Chinese herbs. None 
of her family members had experienced these symp-
toms. Her weight and height were average for her sex 
and age. She looked well with no distress except for 
the inability to move her legs.
Her blood pressure was 174/111 mmHg, body tem-
perature was 36.7ºC, pulse rate was 60 beats/min, 
and respiratory rate was 18/min. She was not anemic, 
and the thyroid gland was not palpable. A decrease in 
bowel movements was noted. She had a regular heart-
beat with no audible murmur, clear vesicular breath 
sounds, no radiofemoral delay, and no renal bruit. 
She had lack of muscle tone and poor muscle power 
(0/5) in both the proximal and distal lower limbs and 
mildly decreased muscle power in the upper limbs 
(4/5). Chest radiography showed no abnormalities and 
electrocardiography revealed sinus rhythm with a 
flattened ST segment.
Initial biochemistry results disclosed severe hypo-
kalemia (potassium, 1.8 mmol/L). Serum sodium level 
was 143 mmol/L, serum calcium was 2.34 mmol/L, 
aspartate aminotransferase was 155 IU/L, alanine 
aminotransferase was 57 IU/L, lactate dehydroge-
nase was 517 IU/L, creatine kinase (CK) was 9837 IU/L 
(rechecked: 12,147 IU/L), and CK-MB was 100 IU/L. 
Urine myoglobulin was elevated (2744.6 ng/mL). Blood 
gas analysis revealed pH of 7.588, PaO2 of 124.8 mmHg, 
PCO2 of 31.5 mmHg, and HCO3
– of 30.3 mmol/L. Se-
vere hypokalemia with rhabdomyolysis was tentatively 
diagnosed. The urine transtubular potassium gradient 
(TTKG) was measured and the level was 5, indicating 
renal potassium wasting.
Rhabdomyolysis was treated with hydration and 
forced alkaline diuresis. Potassium was replaced in-
travenously. Her hypertension was also treated with 
bisoprolol 5 mg qd per oral and spironolactone 25 mg 
bid per oral.
PRA was 0.14 ng · mL–1 · hr–1, and plasma aldosterone 
was 198 pg/mL (19.8 ng/dL); the aldosterone to PRA 
ratio was approximately 141 (ng/dL)/(ng/mL–1 · hr–1). 
Primary hyperaldosteronism was highly suspected. CT 
revealed a left adrenal gland tumor measuring about 
2.5 × 1.5 × 2.5 cm at the largest diameters (Fig. 1). Left 
adrenalectomy was performed and specimens from 
the adrenal gland showed adrenal cortical adenoma 
(Fig. 2).
The hypokalemia, hypertension and plasma aldos-
terone level (97.9 pg/mL) dramatically returned to 
normal following removal of the adrenal adenoma.
3. Discussion
Although hypokalemia is a common finding in primary 
aldosteronism, there are rare reports of cases of hy-
peraldosteronism complicated by hypokalemia and 
rhabdomyolysis [7–9]. Here, we reported a patient who 
presented with severe lower limb weakness and bio-
chemistry data showing hypokalemia, elevated mus-
cle enzymes, metabolic alkalosis, and a rise in urine 
A B
Fig. 1 — Adrenal computed tomography shows an adrenal gland tumor (arrows) measuring approximately 2.5 × 1.5 × 2.5 cm 
at the largest diameters: (A) before contrast medium injection; (B) after contrast medium injection.
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TTKG. In addition, hypertension, elevated plasma 
aldosterone and PRA levels, and a high plasma al-
dosterone to PRA ratio were noted, and adrenal CT 
showed adrenal gland adenoma. Her hypertension 
and hypokalemia were corrected via left adrenalec-
tomy, and histologic examination showed adrenal 
cortical adenoma.
Primary aldosteronism complicated by hypokale-
mia rarely leads to rhabdomyolysis [7–9] because this 
hypokalemia is chronic and plasma potassium tends 
to be relatively stable as the potassium-wasting ef-
fect of excess aldosterone is counterbalanced by the 
potassium-retaining effect of the hypokalemia itself 
[10]. The exact incidence of rhabdomyolysis in pri-
mary aldosteronism is unknown. However, in one re-
port, hypo kalemia was found in 41% of 148 patients 
with primary aldosteronism. Very low levels of serum 
potassium (< 3 mmol/L) were found in a minority (6.7%) 
of these patients. One patient presented with quadri-
plegia; none presented with rhabdomyolysis [11].
Rhabdomyolysis is an uncommon clinical finding 
characterized by muscle necrosis and the release of 
intracellular muscle constituents into the circulation. 
There are a variety of causes which can lead to rhab-
domyolysis, including direct muscle injury such as 
crush injuries (prolonged compression after coma or 
extraordinary physical exertion are the most com-
mon), although heritable muscle enzyme deficiencies, 
electrolyte abnormalities, infections, drugs, toxins, 
and hyperthermia can also be associated with it [1]. 
This patient’s history and initial serum potassium 
level were compatible with hypokalemia-induced 
rhabdomyolysis.
The clinical manifestations of hypokalemia are 
varied and include muscle weakness, fatigue, frank 
ileus, polyuria, fatal cardiac arrhythmias and respira-
tory failure [2,3]. Cardiac complications and rhabdo-
myolysis usually present with serum potassium levels 
< 3 mmol/L [2,4,5]. The differential diagnosis of this 
patient’s severe hypokalemia included: (1) poor in-
take; (2) acute cellular shift from increased insulin 
availability [12–14], elevated beta adrenergic activity 
from catecholamine excess [13,15] and thyrotoxic pe-
riodic paralysis [16–21]; (3) increased gastrointestinal 
loss; and (4) increased renal loss. Hypokalemia with 
TTKG > 4 suggests renal potassium loss due to in-
creased distal potassium secretion. In addition, the 
triad of unexplained renal hypokalemia, hyperten-
sion and metabolic alkalosis should lead to the sus-
picion of primary hyperaldosteronism, as seen in our 
patient. A high plasma aldosterone level (> 500 pmol/L 
or 15 ng/dL) and a high plasma aldosterone to PRA 
A
C
B
Fig. 2 — (A) Gross appearance of the cut section of the left 
adrenal nodule shows a typical golden yellow appearance. 
(B) Microscopic features of the adrenal cortical adenoma: 
clear cells with vacuolated cytoplasm, low nucleocyto-
plasmic ratio, small rounded nuclei and indistinct nucleoli 
(hematoxylin & eosin, 400×). (C) Paradoxical hyperplasia 
of the adjacent zona glomerulosa (hematoxylin & eosin, 
100´).
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ratio [> 30 (ng/dL)/(ng · mL–1 · hr–1)] are the most use-
ful screening tests for suspected primary hyperaldos-
teronism [6,22–24], and these were positive in our 
patient.
Primary hyperaldosteronism can be divided into uni-
lateral adrenal aldosterone hypersecretion (adenoma, 
unilateral hyperplasia or carcinoma), and bilateral al-
dosterone hypersecretion (idiopathic adrenal hyper-
plasia or glucocorticoid remediable aldosteronism). 
Conn’s syndrome, or aldosterone-producing adrenal 
cortical adenoma, is the most common cause of sec-
ondary hypertension. It is caused by an aldosterone-
producing adrenal cortical adenoma, and is important 
because it is surgically curable. Older studies sug-
gested a prevalence of primary aldosteronism of less 
than 1% in hypertensive patients, and it usually oc-
curred between the ages of 30 and 50, with twice as 
many cases in women than in men [23,25]. However, 
the wider application of measurements of aldoster-
one and PRA in recent years has suggested that it 
is probably a more common cause of secondary hy-
pertension than previously thought [26,27]. The final 
dia gnosis is usually made by surgical intervention fol-
lowed by histologic confirmation. The treatment of 
primary hyperaldosteronism due to Conn’s syndrome 
should be with combined medication and surgery. 
Medical control with mineralocorticoid receptor an-
tagonists such as spironolactone is effective in both 
the pre- and postoperative periods [28,29]. Other 
potassium-sparing diuretics such as amiloride and 
triamterene can be used as alternatives but not as 
first-line treatment [30,31].
Unilateral adrenalectomy is usually associated with 
improvement in all patients and a cure in 30–60% of 
hypertensive patients [32]. Correction of hypokalemia 
and marked reductions in aldosterone levels have 
been noted after surgery [33,34]. Although surgery is 
an effective measure, more severe glomerulosclerosis 
and renal arteriolosclerosis, and a worse left ventricu-
lar mass index prior to surgery are related to persis-
tent elevated blood pressure after adrenalectomy in 
some patients [35]. Resolution of hypertension after 
adrenalectomy may be independently associated with 
younger age, lack of family history of hypertension, a 
short duration of hypertension, use of no more than 
two antihypertensive medications during the preop-
erative period, a higher preoperative ratio of plasma 
aldosterone concentration to PRA, and a higher urine 
aldosterone level [34].
4. Conclusion
Rhabdomyolysis may be present in a variety of hy-
pokalemic cases, but its association with Conn’s 
syndrome is relatively uncommon and has only been 
seen in a few case reports [7–9]. Because our patient 
presented with hypokalemia, rhabdomyolysis, hyper-
tension, and metabolic alkalosis, we strongly sus-
pected primary aldosteronism. Our suspicion was 
confirmed by a decrease in PRA, elevation in plasma 
aldosterone level, and a high plasma aldosterone to 
PRA ratio. An adrenal tumor was seen on adrenal gland 
CT. Further confirmation was made when her hyper-
tension and hypokalemia returned to normal after left 
adrenalectomy and histologic examination showed an 
adrenal gland adenoma. Therefore, we recommend 
that primary aldosteronism be considered a possible 
etiology in patients who present with hypokalemia, 
hypertension and rhabdomyolysis.
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